Primary Research · 2009
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Lippman SM, Klein EA, Goodman PJ, et al. · JAMA, 2009
Key finding
Large primary-prevention RCT (n=35,533) found selenium 200µg/day did not prevent prostate cancer — and later follow-up raised concerns about increased type 2 diabetes risk at supplemental doses in selenium-replete populations.
About the supplement
Selenium
Dose · mechanism · evidence grade · safety →
Read the paper
Open on PubMedhttps://pubmed.ncbi.nlm.nih.gov/19066370/
About this page
Formulate maintains a registry of clinical studies cited across its guides and evidence grades. This page links the study metadata to the content that cites it — one canonical entry per landmark study.
The full citation chain is public so readers can verify claims without hunting through individual guide pages. Browse all cited studies →
Note: Study summaries on this page are editorial interpretations of the research. Always consult the primary source before drawing clinical conclusions.